http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2013204550-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_803023bbcbd1fcfd4f7ad657d38cae1a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_28e3113097dd6d28720572e47f2f2407 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4436 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate | 2013-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9fcd00d0d5ecd496c2dfcae3ecac413 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4df380d30e83fca84efc30922b6ecbc8 |
| publicationDate | 2013-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AU-2013204550-A1 |
| titleOfInvention | Methods and drug products for treating alzheimer's disease |
| abstract | Provided herein are drug products with low dose pioglitazone for use in the treatment (e.g., delay of 5 onset) of cognitive impairment of the Alzheimer's type. Methods of manufacture thereof are also provided. Further provided are methods of treatment for Alzheimer's disease including administering a drug product with low dose pioglitazone. The methods may include determining whether 10 the subject is at risk of developing Alzheimer's disease based upon the subject's age and TOMM40 523 GENOTYPE. 42258501 (GHMatters) P93153.AU.1 5/04/13 |
| priorityDate | 2011-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 251.